$206.982,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Gain a solid understanding of pharmacology and make it a part of patient-centered nursing care! Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition makes it easy to learn the principles of pharmacology and drug dosage calculation. A clear guide to pharmacotherapy and safe drug administration, this book uses drug prototypes to provide need-to-know information about key drugs, including dosage, side effects, interactions, and more. Nursing Process summaries enhance your skills in clinical judgment and patient care. Written by a team of nursing experts led by Linda McCuistion, this text provides the pharmacology knowledge you need to succeed on the NCLEX® and as a professional nurse.

  • UNIQUE! Prototype Drug charts provide easy access to key information for representative drugs, including dosages, side effects, interactions, contraindications, pharmacokinetics, and more.
  • UNIQUE! Extensive Drug Calculations chapter features a math review as well as step-by-step instructions for frequently used methods of dosage calculation.
  • UNIQUE! Nursing Process summaries highlight important nursing considerations related to drug therapy and emphasize patient teaching, patient safety, and relevant cultural content.
  • Critical Thinking case studies challenge you to apply your knowledge and analytical skills to realistic patient scenarios, and include answer guidelines on Evolve.
  • Learning features include chapter outlines and objectives, review questions, and learning resources on the Evolve website.
  • Application-level NCLEX® study questions include at least one alternate-style question per chapter, preparing you for the growing pharmacology coverage on the NCLEX Examination.
  • Safety and Quality chapter discusses medication errors, specific nursing measures to promote safety, National Patient Safety Goals, and other safety issues and concerns.
  • Prioritization coverage helps you learn to prioritize nursing care by listing nursing interventions in the order of priority, and a smaller font size differentiates between need-to-know and nice-to-know content.
  • NEW! Next Generation NCLEX® (NGN) examination-style case studies familiarize you to the way that content will be tested in the new NGN exam.
  • NEW! Updated and clinically relevant drug content includes the latest drugs and drug therapies, and removes drugs no longer being used.
  • NEW! Updated Nursing Process summary boxes in each chapter include the Clinical Judgment Model steps along with the nursing process.

1. Unit I. Introduction to Pharmacology - p. xiv 2. 1. Clinical Judgment Management Model (CJMM) and the Nursing Process - p. 1 3. 2. Drug Development and Ethical Considerations - p. 8 4. 3. Pharmacokinetics and Pharmacodynamics - p. 20 5. 4. Pharmacogenetics - p. 33 6. 5. Complementary and Alternative Therapies - p. 38 7. 6. Pediatric Considerations - p. 44 8. 7. Drug Therapy in Older Adults - p. 50 9. 8. Drugs in Substance Use Disorder - p. 56 10. Unit II. Pharmacotherapy and Drug Administration - p. 71 11. 9. Safety and Quality - p. 72 12. 10. Drug Administration - p. 84 13. 11. Drug Calculations - p. 96 14. Systems of Measurement and Conversion Factors - p. 97 15. Interpreting Drug Labels - p. 98 16. Precautions When Reading Drug Labels - p. 99 17. Drug Reconstitution - p. 101 18. Calculation Methods - p. 102 19. Considerations for Enteral Administration - p. 111 20. Considerations for Parenteral Administration - p. 113 21. Calculating Intravenous Flow Rate: Drops Per Minute - p. 120 22. Calculating Intravenous Flow Rate: Milliliters Per Hour - p. 120 23. Answers to Practice Problems - p. 130 24. Unit III. Maintenance of Homeostasis - p. 134 25. 12. Fluid Volume and Electrolytes - p. 135 26. 13. Vitamin and Mineral Replacement - p. 156 27. 14. Nutritional Support - p. 167 28. Unit IV. Autonomic Nervous System Drugs - p. 174 29. 15. Adrenergic Agonists and Antagonists - p. 175 30. 16. Cholinergic Agonists and Antagonists - p. 187 31. Unit V. Central and Peripheral Nervous System Drugs - p. 198 32. 17. Stimulants - p. 199 33. 18. Depressants - p. 206 34. 19. Antiseizure Drugs - p. 219 35. 20. Drugs for Parkinsonism and Alzheimer Disease - p. 228 36. 21. Drugs for Neuromuscular Disorders and Muscle Spasms - p. 241 37. Unit VI. Mental and Behavioral Health Drugs - p. 253 38. 22. Antipsychotics and Anxiolytics - p. 254 39. 23. Antidepressants and Mood Stabilizers - p. 268 40. Unit VII. Pain and Inflammation Management Drugs - p. 278 41. 24. Antiinflammatories - p. 279 42. 25. Analgesics - p. 295 43. Unit VIII. Antimicrobial Drugs - p. 311 44. 26. Penicillins, Other Beta-Lactams, and Cephalosporins - p. 312 45. 27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides - p. 324 46. 28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 330 47. 29. Sulfonamides and Nitroimidazoles Antibiotics - p. 339 48. 30. Antituberculars, Antifungals, and Antivirals - p. 345 49. 31. Antimalarials, Anthelmintics, and Peptides - p. 360 50. Unit IX. Immunologic Drugs - p. 370 51. 32. HIV- and AIDS-Related Drugs - p. 371 52. 33. Transplant Drugs - p. 386 53. 34. Vaccines - p. 398 54. Unit X. Antineoplastics and Biologic Response Modifiers - p. 408 55. 35. Anticancer Drugs - p. 409 56. 36. Targeted Therapies to Treat Cancer - p. 434 57. 37. Biologic Response Modifiers - p. 453 58. Unit XI. Respiratory Drugs - p. 462 59. 38. Upper Respiratory Disorders - p. 463 60. 39. Lower Respiratory Disorders - p. 472 61. Unit XII. Cardiovascular Drugs - p. 485 62. 40. Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 486 63. 41. Diuretics - p. 507 64. 42. Antihypertensives - p. 518 65. 43. Anticoagulants, Antiplatelets, and Thrombolytics - p. 533 66. 44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 544 67. Unit XIII. Gastrointestinal Drugs - p. 552 68. 45. Gastrointestinal Tract Disorders - p. 553 69. 46. Antiulcer Drugs - p. 569 70. Unit XIV. Eye, Ear, and Skin Drugs - p. 580 71. 47. Eye and Ear Disorders - p. 581 72. 48. Dermatologic Disorders - p. 597 73. Unit XV. Endocrine Drugs - p. 608 74. 49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 609 75. 50. Antidiabetics - p. 625 76. Unit XVI. Renal and Urologic Drugs - p. 638 77. 51. Urinary Disorders - p. 639 78. Unit XVII. Reproductive and Gender-Related Drugs - p. 646 79. 52. Pregnancy and Preterm Labor - p. 647 80. 53. Labor, Delivery, and Postpartum - p. 663 81. 54. Neonatal and Newborn - p. 682 82. 55. Women’s Reproductive Health - p. 687 83. 56. Men’s Reproductive Health - p. 713 84. 57. Sexually Transmitted Infections - p. 722 85. Unit XVIII. Adult and Pediatric Emergency Drugs - p. 730 86. 58. Adult and Pediatric Emergency Drugs - p. 731 87. Appendix A. Answers to Review Questions - p. 747 88. Appendix B. Solution Compatibility Chart - p. 749 89. Appendix C. Immunizations - p. 751 90. Bibliography - p. 754 91. Glossary - p. 757 92. Index - p. 768

Descripcion
Descripción

Gain a solid understanding of pharmacology and make it a part of patient-centered nursing care! Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition makes it easy to learn the principles of pharmacology and drug dosage calculation. A clear guide to pharmacotherapy and safe drug administration, this book uses drug prototypes to provide need-to-know information about key drugs, including dosage, side effects, interactions, and more. Nursing Process summaries enhance your skills in clinical judgment and patient care. Written by a team of nursing experts led by Linda McCuistion, this text provides the pharmacology knowledge you need to succeed on the NCLEX® and as a professional nurse.

  • UNIQUE! Prototype Drug charts provide easy access to key information for representative drugs, including dosages, side effects, interactions, contraindications, pharmacokinetics, and more.
  • UNIQUE! Extensive Drug Calculations chapter features a math review as well as step-by-step instructions for frequently used methods of dosage calculation.
  • UNIQUE! Nursing Process summaries highlight important nursing considerations related to drug therapy and emphasize patient teaching, patient safety, and relevant cultural content.
  • Critical Thinking case studies challenge you to apply your knowledge and analytical skills to realistic patient scenarios, and include answer guidelines on Evolve.
  • Learning features include chapter outlines and objectives, review questions, and learning resources on the Evolve website.
  • Application-level NCLEX® study questions include at least one alternate-style question per chapter, preparing you for the growing pharmacology coverage on the NCLEX Examination.
  • Safety and Quality chapter discusses medication errors, specific nursing measures to promote safety, National Patient Safety Goals, and other safety issues and concerns.
  • Prioritization coverage helps you learn to prioritize nursing care by listing nursing interventions in the order of priority, and a smaller font size differentiates between need-to-know and nice-to-know content.
  • NEW! Next Generation NCLEX® (NGN) examination-style case studies familiarize you to the way that content will be tested in the new NGN exam.
  • NEW! Updated and clinically relevant drug content includes the latest drugs and drug therapies, and removes drugs no longer being used.
  • NEW! Updated Nursing Process summary boxes in each chapter include the Clinical Judgment Model steps along with the nursing process.

1. Unit I. Introduction to Pharmacology - p. xiv 2. 1. Clinical Judgment Management Model (CJMM) and the Nursing Process - p. 1 3. 2. Drug Development and Ethical Considerations - p. 8 4. 3. Pharmacokinetics and Pharmacodynamics - p. 20 5. 4. Pharmacogenetics - p. 33 6. 5. Complementary and Alternative Therapies - p. 38 7. 6. Pediatric Considerations - p. 44 8. 7. Drug Therapy in Older Adults - p. 50 9. 8. Drugs in Substance Use Disorder - p. 56 10. Unit II. Pharmacotherapy and Drug Administration - p. 71 11. 9. Safety and Quality - p. 72 12. 10. Drug Administration - p. 84 13. 11. Drug Calculations - p. 96 14. Systems of Measurement and Conversion Factors - p. 97 15. Interpreting Drug Labels - p. 98 16. Precautions When Reading Drug Labels - p. 99 17. Drug Reconstitution - p. 101 18. Calculation Methods - p. 102 19. Considerations for Enteral Administration - p. 111 20. Considerations for Parenteral Administration - p. 113 21. Calculating Intravenous Flow Rate: Drops Per Minute - p. 120 22. Calculating Intravenous Flow Rate: Milliliters Per Hour - p. 120 23. Answers to Practice Problems - p. 130 24. Unit III. Maintenance of Homeostasis - p. 134 25. 12. Fluid Volume and Electrolytes - p. 135 26. 13. Vitamin and Mineral Replacement - p. 156 27. 14. Nutritional Support - p. 167 28. Unit IV. Autonomic Nervous System Drugs - p. 174 29. 15. Adrenergic Agonists and Antagonists - p. 175 30. 16. Cholinergic Agonists and Antagonists - p. 187 31. Unit V. Central and Peripheral Nervous System Drugs - p. 198 32. 17. Stimulants - p. 199 33. 18. Depressants - p. 206 34. 19. Antiseizure Drugs - p. 219 35. 20. Drugs for Parkinsonism and Alzheimer Disease - p. 228 36. 21. Drugs for Neuromuscular Disorders and Muscle Spasms - p. 241 37. Unit VI. Mental and Behavioral Health Drugs - p. 253 38. 22. Antipsychotics and Anxiolytics - p. 254 39. 23. Antidepressants and Mood Stabilizers - p. 268 40. Unit VII. Pain and Inflammation Management Drugs - p. 278 41. 24. Antiinflammatories - p. 279 42. 25. Analgesics - p. 295 43. Unit VIII. Antimicrobial Drugs - p. 311 44. 26. Penicillins, Other Beta-Lactams, and Cephalosporins - p. 312 45. 27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides - p. 324 46. 28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 330 47. 29. Sulfonamides and Nitroimidazoles Antibiotics - p. 339 48. 30. Antituberculars, Antifungals, and Antivirals - p. 345 49. 31. Antimalarials, Anthelmintics, and Peptides - p. 360 50. Unit IX. Immunologic Drugs - p. 370 51. 32. HIV- and AIDS-Related Drugs - p. 371 52. 33. Transplant Drugs - p. 386 53. 34. Vaccines - p. 398 54. Unit X. Antineoplastics and Biologic Response Modifiers - p. 408 55. 35. Anticancer Drugs - p. 409 56. 36. Targeted Therapies to Treat Cancer - p. 434 57. 37. Biologic Response Modifiers - p. 453 58. Unit XI. Respiratory Drugs - p. 462 59. 38. Upper Respiratory Disorders - p. 463 60. 39. Lower Respiratory Disorders - p. 472 61. Unit XII. Cardiovascular Drugs - p. 485 62. 40. Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 486 63. 41. Diuretics - p. 507 64. 42. Antihypertensives - p. 518 65. 43. Anticoagulants, Antiplatelets, and Thrombolytics - p. 533 66. 44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 544 67. Unit XIII. Gastrointestinal Drugs - p. 552 68. 45. Gastrointestinal Tract Disorders - p. 553 69. 46. Antiulcer Drugs - p. 569 70. Unit XIV. Eye, Ear, and Skin Drugs - p. 580 71. 47. Eye and Ear Disorders - p. 581 72. 48. Dermatologic Disorders - p. 597 73. Unit XV. Endocrine Drugs - p. 608 74. 49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 609 75. 50. Antidiabetics - p. 625 76. Unit XVI. Renal and Urologic Drugs - p. 638 77. 51. Urinary Disorders - p. 639 78. Unit XVII. Reproductive and Gender-Related Drugs - p. 646 79. 52. Pregnancy and Preterm Labor - p. 647 80. 53. Labor, Delivery, and Postpartum - p. 663 81. 54. Neonatal and Newborn - p. 682 82. 55. Women’s Reproductive Health - p. 687 83. 56. Men’s Reproductive Health - p. 713 84. 57. Sexually Transmitted Infections - p. 722 85. Unit XVIII. Adult and Pediatric Emergency Drugs - p. 730 86. 58. Adult and Pediatric Emergency Drugs - p. 731 87. Appendix A. Answers to Review Questions - p. 747 88. Appendix B. Solution Compatibility Chart - p. 749 89. Appendix C. Immunizations - p. 751 90. Bibliography - p. 754 91. Glossary - p. 757 92. Index - p. 768

Indice
Autores
Muestra
Ficha Técnica